Background. Although both the presence and progression over time of vascular calcification have been shown to independently predict cardiovascular disease and mortality in chronic dialysis patients, the impact of the pattern of accumulation of abdominal aortic calcification on mortality has not yet been investigated. Methods. We conducted a longitudinal study at a dialysis hospital in Hokkaido, Japan from 2005 to 2014. An abdominal calcification index (ACI) was generated for 396 patients from their annual abdominal computed tomography (CT) scans. The trajectories of ACIs during the first 2 years were classified using group-based trajectory modeling into four groups; stable (29.0%), slow increase (29.2%), rapid nonlinear increase (24.4%) and advanced with slow increase (17.4%). Incidence rates by group of all-cause mortality during the follow-up period (mean of 4.5 years) were investigated using the Cox proportional hazard model. Results. Compared with the stable trajectory, both the rapid nonlinear increase and the advanced with slow increase trajectories were associated with an increased risk of death [adjusted hazard ratios (HR) 1.91; 95% confidence interval (CI) 1.02-3.58 and adjusted HR 2.79; 95% CI: 1.44-5.11, respectively]. Sensitivity analyses indicated that ACI trajectories were associated with subsequent mortality, while ACI at individual time points was not. Conclusions. Chronic hemodialysis patients with a trajectory of longitudinal high or rapid accumulation of vascular calcification over time were at a higher risk of death. Individual trajectories of vascular calcification may be suggested to allow for more accurate mortality risk calculations than one-time assessment.
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I N T R O D U C T I O N
The presence of abdominal aortic calcification has been shown to be associated with all-cause mortality in maintenance hemodialysis (HD) patients, regardless of the methods employed to assess and measure the calcification [1] [2] [3] [4] [5] [6] [7] . Vascular calcification tends to progress over time in maintenance HD patients during dialysis [8] . Although the precise pathogenesis remains unclear, it has been attributed to the large calcium mass transfer and phosphate retention that occur with administration of calcitriol in the management of hyperparathyroidism and the use of calcium carbonate as a primary phosphate-binding agent [9] . As such, not only measuring the amount of calcification at one point, but also long-term monitoring of calcification, may be advisable [10] ; however, to the best of our knowledge, the trajectory of abdominal aortic calcification has not been investigated regarding its association with adverse outcomes.
Among studies focusing on aortic arch or coronary calcification [11] [12] [13] [14] , the prevalence and the progression over time were separately assessed to investigate their associations with mortality. One study showed that both the presence and progression of aortic arch calcification were independently associated with mortality [12] , while others suggested that only progression of calcification was a strong predictor of mortality [11] or that progression itself was not predictive of mortality in patients with no calcification at baseline [13] . A part of this controversy V C The Author 2017. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.
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may be related to their analytical methodology; progression in these studies was defined as a dichotomized variable, that is, 'þprogression' or 'Àprogression', which presumably omits a possible variability of trajectories of progression over time.
Here, to assess the possible impact of abdominal calcification trajectory on mortality, we examined the trajectories of abdominal calcification over time and investigated their association with all-cause mortality.
M A T E R I A L S A N D M E T H O D S

Population
A total of 470 chronic HD patients at Kitasaito Hospital in Hokkaido, Japan, who had undergone annual abdominal computed tomography (CT) from January 2005 to June 2014 were included. To be enrolled, they had to be 18 years or older.
The calendar year of an individual's 'Year 1' was defined as the year when the first CT was available during the study period, and Years 2 and 3 followed accordingly. For the present study, to investigate whether abdominal aortic calcification trajectories from Year 1 to Year 3 were associated with subsequent mortality until June 2014, we excluded those who died or were lost to follow-up between Year 1 and Year 3, leading to an analytic cohort of 396 patients. The study adhered to the Declaration of Helsinki and was approved by the ethics committee of Kitasaito Hospital.
Assessment of abdominal aortic calcification
We used the aortic calcification index (ACI) score for the measurement of abdominal calcification, as previously described [10, 15, 16] . The ACI uses unenhanced abdominal CT and assesses 10 sections of the abdominal aorta obtained at 10-mm intervals upward from the iliac bifurcation. The ACI expresses calcification in 12 sectors as a percentage and 10 sections are averaged. To optimize reproducibility, all scans were performed by the same hospital staff technologist using the same CT equipment under blinded conditions.
Other variables
Information on demography, primary kidney disease, age at the start of dialysis and comorbidities was collected at Year 3. In HD patients, blood samples were drawn before and after each monitoring dialysis session using routine laboratory methods. Data on residual biochemistry, dialysis characteristics and medication use that were closest to the date of the CT scan at Year 3 were also collected. Mean values of three measurements of plasma calcium, C-reactive protein (CRP), phosphorus and albumin were calculated. Serum intact parathyroid hormone (iPTH) and glycoalbumin levels were measured once. Calcium concentrations (mg/ dL) were corrected for albumin concentrations (g/dL) using the following formula when its value was below 4: corrected calcium ¼ calcium þ 0.8 Â (4 À albumin) [17] .
Statistical analysis
First, we evaluated the trajectories of ACIs over the first two years (i.e. Year 1 through Year 3) using the STATA Traj procedure [18] , which adopts a well-established SAS-based procedure for estimating group-based trajectory models [19, 20] . The STATA Traj identifies groups of individuals following similar developmental trajectories, calculates the probability of each subject belonging to each group, then assigns each subject to the group with the largest probability. Parameters are estimated by a maximum likelihood approach using a general quasiNewton maximization procedure. Each group trajectory has its own intercept and linear and quadratic parameters to indicate the trajectory as a function of duration from baseline. As the ACI ranges from 0 to 100, a censored normal distribution was used. We evaluated the optimal number of trajectories and polynomial degree of each trajectory by first requiring each group to include at least 10% of patients, which is twice the number usually recommended [21] , due to our sample size. For each model specifying a given number of trajectories, we tested linear and quadratic terms to determine what shapes best fit the data (terms were considered significant if P < 0.10). Using the resulting models, we evaluated the appropriate number of trajectories by calculating the estimated log Bayes factor, which compares Bayesian information criterion (BIC) values between models. These procedures indicated that a model with four trajectories (one intercept, two linear and one quadratic) was superior to models with fewer trajectories. Although a model with five trajectories was associated with further improvement in model fit, this model yielded a trajectory group with <10% of patients. Therefore, we selected the four-trajectory model for use in subsequent analyses. We used the v 2 test and the Kruskal-Wallis test to explore whether the independent samples that were defined by the group were from the same population.
Second, to examine the association between the ACI trajectory membership and the risk of death, we plotted KaplanMeier survival curves and constructed Cox proportional hazards models. The follow-up period started on the date of the CT scan in Year 3 and ended at the time of death, termination of maintenance HD at the hospital or 30 June 2014, whichever came first. Model 1 was unadjusted. Adjustment was made for factors that differed between the groups (P < 0.05). Model 2 was adjusted for factors that were assumed to have been established no later than the initial period of the trajectory [demography, HD duration, smoking status and diabetes mellitus (DM)]. The remaining factors that differed across the groups (comorbidities other than DM and the levels of serum albumin and CRP) were added separately in Model 3 since they might be on the causal pathway linking aortic calcification and mortality. Further, we additionally adjusted Model 2 for use of medications that could alter the progression of calcification, such as vitamin D, calcimimetics and statins [22] in Model 4.
In sensitivity analyses, we investigated whether trajectories were more informative than single-point ACI by additional adjustment of Model 2 separately for ACI at Years 1 and 2. All statistical analyses except for STATA Traj were conducted using commercial software (SSPS version 22, SPSS, Inc., Chicago, IL, USA). Based on BIC, we identified four groups of trajectories ( Figure 1 ): 29.0% of patients were classified as having normal/ near normal baseline with little increase (Group 1: stable); 29.2% had a near-normal baseline with slow increase (Group 2: slow increase); 24.4% started out with a heterogeneous baseline with rapid nonlinear increase (Group 3: rapid nonlinear increase); while the remaining 17.4% had advanced calcification with slightly increasing levels (Group 4: advanced with slow increase).
R E S U L T S
Parameters of the four groups and absolute model fit statistics are shown in Table 2 . The initial status (grand mean score at Year 1) of ACI varied across the groups in an orderly manner, ranging from 4.9% to 63.9%. Significant linear effects for ACI were positive in Groups 2, 3 and 4, confirming that ACI increased over time. The rate of increase was similar between Groups 2 and 4 (b ¼ 3.6 for Group 2, b ¼ 2.8 for Group 4), while the greatest rate of increase was observed in Group 3 (b ¼ 10.7). A small quadratic effect was observed in Group 3 (b ¼ À1.5), indicating that the rate of calcification decreased slightly over time. The average posterior probabilities of group membership and the odds of correct classification for each trajectory were large, indicating strong reliability of the model [23] .
As summarized in Table 3 , age, sex, smoking status, HD duration, comorbidities and serum albumin and CRP levels obtained at Year 3 significantly differed across the groups. In particular, Group 1 had distinct characteristics compared with the other groups; the subjects were younger, disproportionately female and nonsmokers. They were less likely to have DM and vascular comorbidities (i.e. coronary artery disease and stroke). Group 2 had the shortest average HD duration, while Group 4 had the longest. The mean serum albumin levels of Groups 1 and 2 were higher than those of Groups 3 and 4. Group 1 had lower CRP levels compared with Group 4. One of the vitamin D analogs, intravenous calcitriol, was less likely to be used among Group 1 patients compared with those in Groups 2 and 4; however, overall vitamin D use was similar across the groups.
Overall, 112 patients (28.2%) died, a mean (SD) of 3.6 (1.5) years after Year 3. Kaplan-Meier survival curves ( Figure  2 ) for each group indicated that the groups had significant differences in mortality (P < 0.001 by the log-rank test). The results of unadjusted and adjusted Cox proportional hazards regression models are summarized in Table 4 . Compared with individuals in Group 1, those in Groups 3 and 4 were significantly more likely to die during the follow-up period even after adjustment for possible confounders in Model 2, while those in Group 2 were not. Further adjustment for vascular comorbidities and serum albumin levels attenuated the associations, leading the association between Group 3 and mortality to no longer be significant. The results of Model 4 with additional adjustment for cinacalcet, vitamin D and statin use were almost identical to those of Model 2.
Sensitivity analyses examining whether ACI trajectories better predicted associations with the risk of death than one-time- 
D I S C U S S I O N
This study examined the association between 2-year trajectories of abdominal aortic calcification and all-cause mortality over 4.5 years among 396 chronic HD patients. Trajectories of abdominal aortic calcification were classified into four groups: Group 1 stable (29.0%), Group 2 slow increase (29.2%), Group 3 rapid nonlinear increase (24.4%) and Group 4 advanced with slow increase (17.4%). Groups 3 and 4, which had high or rapid accumulation of vascular calcification over time, were at a higher risk of death, and the trajectory of calcification may predict mortality more accurately than one-time assessment. Despite similar slight linear increases observed in Groups 2 and 4, their associations with mortality were completely different: only Group 4 was at high risk of increased mortality. This finding is similar to that of a previous study showing that progression itself was not predictive of mortality in patients with no calcification at baseline [13] . This may imply that the associations between progression of calcification and mortality are highly dependent on the extent of baseline calcification; however, given that additional adjustment for ACI at Years 1 and 2 did not alter the obtained associations, this may suggest that neither the amount of calcification at one point in time nor whether or not it progresses is informative enough to predict mortality, and that monitoring the pattern of calcification over time may be justified.
Abdominal aortic calcification was highly prevalent in patients enrolled in this study (96.2% were ACI 6 ¼ 0%) and progression of calcification over time was also common. However, there was a limited number of HD patients experiencing little or no calcification over time (i.e. Group 1); these patients were more likely to be female, nonsmokers and without DM or vascular comorbidities. These characteristics have much in common with factors associated with the absence of aortic calcification described in previous studies [1, 4, 6, 11, 12, 24] . One factor was inconsistent, however; namely, HD duration. In these previous studies, those without calcification generally had a shorter HD duration than those with calcification [1, 4, 6, 8, 15, 24] . In contrast, the HD duration of Group 1 in our study had a highly right-skewed distribution, and included patients with the longest HD duration in our sample. Investigation of factors that were not measured in this study, such as medication adherence and lifestyle in Group 1 patients with a long duration of HD, in future studies might reveal ways to better manage the progression of calcification.
We found that patients in Groups 3 and 4 were quite similar in their baseline characteristics; they were more likely to be older and smokers, and have a longer HD duration, more comorbidities (DM, coronary artery disease and stroke) and lower albumin levels. Factors differentiating Group 3 from Group 4, however, were not apparent in our study. Further studies with an aim to identify any modifiable risk factors of being in Group 3 or 4 are worth conducting in the future.
A strength of the present study is that it is the first study to identify calcification trajectories of abdominal aortic calcification among chronic HD patients by a trajectory model approach. This approach has been used to describe heterogeneity of disease/disability processes [25] [26] [27] . Although little is known about the natural course of vascular calcification, we were able to characterize calcification progression by the four patterns. Previous studies have commonly grouped HD patients based on predefined cut-off values of the calcification index into 'þprogression' and 'Àprogression' [1, 2, 5, 28] , which may not Trajectories of abdominal aortic calcification Kruskal-Wallis test was performed for continuous variables to test whether the four independent samples that were defined by the group were from the same population. Pairwise multiple comparisons were also made. Chi-square test was performed for dichotomized variables. To identify differences were among the populations, a chi-squared test for each pair was performed. fully reflect the different patterns of calcification progression and their differences in mortality risk. Several limitations of this study warrant mention. First, this is a single-site study with a small sample size, leading to a limitation in generalizability. In particular, predictive values for mortality using the trajectories should be separately compared with those of baseline and progression in larger studies. Second, the ACI we used in this study as a measurement of calcification requires a CT scan, which exposes patients to more radiation than a traditional X-ray. Several less invasive methods are available to detect and measure the degree of vascular calcification [29] . Plain radiography appears to be more commonly used to assess not only aortic arch calcification [11, [30] [31] [32] [33] , but also abdominal aortic calcification. However, despite being a convenient and inexpensive method, quantification remains an issue (i.e. an increase in the amount of calcification compared with that in a previous X-ray is defined as 'progression'). On the other hand, electron beam CT (EBCT) and multidetector-row helical CT (MDCT) are excellent for quantitative evaluation of coronary artery calcification, but are expensive to perform and are not readily available in routine clinical practice. Although CT was not recommended as a routine or screening technique for vascular calcification in Kidney Disease: Improving Global Outcomes (KDIGO) due to its high cost and radiation exposure [34] , this method was the most convenient and safe solution for monitoring abdominal calcification over time for determining FIGURE 2: Associations between the abdominal calcification trajectory group and survival among 396 adult HD patients. Kaplan-Meier survival curves show the incidence of death according to abdominal calcification trajectory groups (P < 0.001 by the log-rank test). Trajectories of abdominal aortic calcification the ACI in a medical practice where annual unenhanced abdominal CTs are routinely conducted to screen for abdominal malignancy.
Management of chronic kidney disease-associated mineral bone disorder by non-calcium-containing phosphate binders [7, 35, 36] or calcimimetics [37] has been shown to attenuate the progression of vascular calcification. Therapeutic interventions aimed at managing some known factors associated with vascular calcification, such as high blood pressure [38] , smoking status or inflammation [39] , may also alter the development of vascular calcification. Monitoring the trajectory of aortic calcification among chronic HD patients may, therefore, provide useful information on who should be given priority for receiving such interventions. 
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